331 related articles for article (PubMed ID: 29984646)
1. Focusing on the Influenza Virus Polymerase Complex: Recent Progress in Drug Discovery and Assay Development.
Zhang J; Hu Y; Musharrafieh R; Yin H; Wang J
Curr Med Chem; 2019; 26(13):2243-2263. PubMed ID: 29984646
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface.
Yuan S; Chu H; Ye J; Singh K; Ye Z; Zhao H; Kao RY; Chow BK; Zhou J; Zheng BJ
Antiviral Res; 2017 Jan; 137():58-66. PubMed ID: 27840201
[TBL] [Abstract][Full Text] [Related]
3. The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design.
Stevaert A; Naesens L
Med Res Rev; 2016 Nov; 36(6):1127-1173. PubMed ID: 27569399
[TBL] [Abstract][Full Text] [Related]
4. Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics.
Zhou Z; Liu T; Zhang J; Zhan P; Liu X
Drug Discov Today; 2018 Mar; 23(3):503-518. PubMed ID: 29339107
[TBL] [Abstract][Full Text] [Related]
5. Identification of influenza virus inhibitors which disrupt of viral polymerase protein-protein interactions.
Chase G; Wunderlich K; Reuther P; Schwemmle M
Methods; 2011 Oct; 55(2):188-91. PubMed ID: 21867756
[TBL] [Abstract][Full Text] [Related]
6. Influenza virus polymerase subunits co-evolve to ensure proper levels of dimerization of the heterotrimer.
Chen KY; Santos Afonso ED; Enouf V; Isel C; Naffakh N
PLoS Pathog; 2019 Oct; 15(10):e1008034. PubMed ID: 31581279
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of an essential interaction between influenza polymerase and Pol II CTD.
Lukarska M; Fournier G; Pflug A; Resa-Infante P; Reich S; Naffakh N; Cusack S
Nature; 2017 Jan; 541(7635):117-121. PubMed ID: 28002402
[TBL] [Abstract][Full Text] [Related]
8. Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Endonuclease activity and evaluation of inhibitors.
Xing W; Barauskas O; Kirschberg T; Niedziela-Majka A; Clarke M; Birkus G; Weissburg P; Liu X; Schultz BE; Sakowicz R; Kwon H; Feng JY
PLoS One; 2017; 12(8):e0181969. PubMed ID: 28809961
[TBL] [Abstract][Full Text] [Related]
9. Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance.
Nannetti G; Massari S; Mercorelli B; Bertagnin C; Desantis J; Palù G; Tabarrini O; Loregian A
Antiviral Res; 2019 May; 165():55-64. PubMed ID: 30885750
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus.
He X; Zhou J; Bartlam M; Zhang R; Ma J; Lou Z; Li X; Li J; Joachimiak A; Zeng Z; Ge R; Rao Z; Liu Y
Nature; 2008 Aug; 454(7208):1123-6. PubMed ID: 18615018
[TBL] [Abstract][Full Text] [Related]
11. Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral Attenuation.
Da Costa B; Sausset A; Munier S; Ghounaris A; Naffakh N; Le Goffic R; Delmas B
J Virol; 2015 Jun; 89(12):6376-90. PubMed ID: 25855727
[TBL] [Abstract][Full Text] [Related]
12. Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-Protein Interaction as a Target for Next-Generation Anti-influenza Therapeutics.
Massari S; Goracci L; Desantis J; Tabarrini O
J Med Chem; 2016 Sep; 59(17):7699-718. PubMed ID: 27046062
[TBL] [Abstract][Full Text] [Related]
13. [Structural and Biochemical Analyses on the RNA-dependent RNA Polymerase of Influenza Virus for Development of Novel Anti-influenza Agents].
Hatakeyama D
Yakugaku Zasshi; 2017; 137(2):205-214. PubMed ID: 28154333
[TBL] [Abstract][Full Text] [Related]
14. Mapping the domain structure of the influenza A virus polymerase acidic protein (PA) and its interaction with the basic protein 1 (PB1) subunit.
Guu TS; Dong L; Wittung-Stafshede P; Tao YJ
Virology; 2008 Sep; 379(1):135-42. PubMed ID: 18657841
[TBL] [Abstract][Full Text] [Related]
15. Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors.
Jones JC; Kumar G; Barman S; Najera I; White SW; Webby RJ; Govorkova EA
mBio; 2018 Apr; 9(2):. PubMed ID: 29691337
[TBL] [Abstract][Full Text] [Related]
16. Screening for Novel Small-Molecule Inhibitors Targeting the Assembly of Influenza Virus Polymerase Complex by a Bimolecular Luminescence Complementation-Based Reporter System.
Li C; Wang Z; Cao Y; Wang L; Ji J; Chen Z; Deng T; Jiang T; Cheng G; Qin FX
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031371
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel compound with antiviral activity against influenza A virus depending on PA subunit of viral RNA polymerase.
Yamada K; Koyama H; Hagiwara K; Ueda A; Sasaki Y; Kanesashi SN; Ueno R; Nakamura HK; Kuwata K; Shimizu K; Suzuki M; Aida Y
Microbes Infect; 2012 Aug; 14(9):740-7. PubMed ID: 22441116
[TBL] [Abstract][Full Text] [Related]
18. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs.
Fodor E; Crow M; Mingay LJ; Deng T; Sharps J; Fechter P; Brownlee GG
J Virol; 2002 Sep; 76(18):8989-9001. PubMed ID: 12186883
[TBL] [Abstract][Full Text] [Related]
19. Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening.
Lo CY; Li OT; Tang WP; Hu C; Wang GX; Ngo JC; Wan DC; Poon LL; Shaw PC
Sci Rep; 2018 Feb; 8(1):2280. PubMed ID: 29396435
[TBL] [Abstract][Full Text] [Related]
20. A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly.
Li C; Ba Q; Wu A; Zhang H; Deng T; Jiang T
FEBS J; 2013 Feb; 280(4):1139-49. PubMed ID: 23279951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
